title: The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care.
abstract: The objective was to evaluate the effect of an assessment strategy using the computer decision support system (the GRAIDS software), on the management of familial cancer risk in British general practice in comparison with best current practice. The design included cluster randomised controlled trial, and involved forty-five general practice teams in East Anglia, UK. Randomised to GRAIDS (Genetic Risk Assessment on the Internet with Decision Support) support (intervention n=23) or comparison (n=22). Training in the new assessment strategy and access to the GRAIDS software (GRAIDS arm) was conducted, compared with an educational session and guidelines about managing familial breast and colorectal cancer risk (comparison) were mailed. Outcomes were measured at practice, practitioner and patient levels. The primary outcome measure, at practice level, was the proportion of referrals made to the Regional Genetics Clinic for familial breast or colorectal cancer that were consistent with referral guidelines. Other measures included practitioner confidence in managing familial cancer (GRAIDS arm only) and, in patients: cancer worry, risk perception and knowledge about familial cancer. There were more referrals to the Regional Genetics Clinic from GRAIDS than comparison practices (mean 6.2 and 3.2 referrals per 10 000 registered patients per year; mean difference 3.0 referrals; 95% confidence interval (CI) 1.2-4.8; P=0.001); referrals from GRAIDS practices were more likely to be consistent with referral guidelines (odds ratio (OR)=5.2; 95% CI 1.7-15.8, P=0.006). Patients referred from GRAIDS practices had lower cancer worry scores at the point of referral (mean difference -1.44 95% CI -2.64 to -0.23, P=0.02). There were no differences in patient knowledge about familial cancer. The intervention increased GPs' confidence in managing familial cancer. Compared with education and mailed guidelines, assessment including computer decision support increased the number and quality of referrals to the Regional Genetics Clinic for familial cancer risk, improved practitioner confidence and had no adverse psychological effects in patients. Trials are registered under N0181144343 in the UK National Research Register.
authors: General Practice, School of Primary, Aboriginal and Rural Health Care, University of Western Australia, 328 Stirling Highway, Claremont, Western Australia 6010, Australia. jon.emery@uwa.edu.au
authors: J
authors: J
authors: Emery
authors: H
authors: H
authors: Morris
authors: R
authors: R
authors: Goodchild
authors: T
authors: T
authors: Fanshawe
authors: A T
authors: AT
authors: Prevost
authors: M
authors: M
authors: Bobrow
authors: A L
authors: AL
authors: Kinmonth
mesh_terms: D000328:Adult; D000465:Algorithms; D016000:Cluster Analysis; D003658:Decision Making, Computer-Assisted; D020000:Decision Support Systems, Clinical / Q000706:statistics & numerical data; D004739:England; D005194:Family Practice / Q000379:methods*; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008875:Middle Aged; D009369:Neoplasms / Q000235:genetics* / Q000628:therapy*; D010818:Practice Patterns, Physicians'; D011320:Primary Health Care / Q000379:methods*; D018570:Risk Assessment
references: BMJ. 2000 Mar 11;320(7236):686-90
references: 10710578
references: BMJ. 2005 Nov 5;331(7524):1047
references: 16243849
references: Lancet. 2000 Jun 10;355(9220):2015-20
references: 10885351
references: BMJ. 2000 Sep 16;321(7262):694-6
references: 10987780
references: BMJ. 2001 Feb 3;322(7281):279-82
references: 11157532
references: Genet Med. 1998 Nov-Dec;1(1):13-21
references: 11261424
references: Lancet. 2001 Jul 7;358(9275):56-63
references: 11454400
references: Br J Cancer. 2001 Jul 20;85(2):166-70
references: 11461071
references: Br J Gen Pract. 2001 Oct;51(471):817-21
references: 11677705
references: BMJ. 2002 Apr 13;324(7342):880-2
references: 11950738
references: J Med Genet. 2002 Oct;39(10):779-81
references: 12362040
references: Fam Pract. 2002 Dec;19(6):587-90
references: 12429659
references: Lancet. 2003 Jan 25;361(9354):296-300
references: 12559863
references: Am J Prev Med. 2003 Feb;24(2):128-35
references: 12568818
references: Am J Prev Med. 2003 Feb;24(2):190-8
references: 12568826
references: N Engl J Med. 2003 Jun 5;348(23):2339-47
references: 12788999
references: J Natl Cancer Inst. 2004 Jan 21;96(2):122-33
references: 14734702
references: J Natl Cancer Inst. 2004 Feb 18;96(4):261-8
references: 14970275
references: Nat Rev Genet. 2004 Oct;5(10):783-90
references: 15510169
references: Am J Hum Genet. 1991 Feb;48(2):232-42
references: 1990835
references: Br J Cancer. 1999 Feb;79(5-6):868-74
references: 10070883
references: BMJ. 1999 Jul 3;319(7201):32-6
references: 10390458
references: Health Technol Assess. 2005 Feb;9(3):iii-iv, 1-126
references: 15694064
references: BMJ. 2005 Apr 2;330(7494):765
references: 15767266
references: Lancet. 2005 May 21-27;365(9473):1769-78
references: 15910949
references: Ann Hum Biol. 2005 Mar-Apr;32(2):218-27
references: 16096220
references: BMJ. 2000 Jul 1;321(7252):28-32
references: 10875832